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ABSTRACT 
The effects of administering methamphetamine to iprindole-treated 
rats on serotonergic metabolism in the cerebral cortex, neostriatum and 
hypothalamus and on dopamine metabolism in the neostriatum have been 
investigated. Methamphetamine (17.5 mg/kg, i.p.) was administered two 
hours after iprindo1e (10 mg/kg, i.p.). Three and 7 days after injec-
tion significant decreases (p <0.05) were seen in tryptophan hydroxy-
lase (TPH) activity, serotonin (5-HT) and 5-hydroxyindo1eacetic acid 
(5-HlAA) concentrations in all brain regions examined. A significant 
decrease in TPH activity was observed after 1 day; however, 5-HT and 
5-HIAA concentrations were not significantly different from saline 
controls. After 14 days, all parameters were decreased with the excep-
tion of hypothalamic TPH activity, which was not significantly different 
from saline control. Neostriata1 tyrosine hydroxylase (TH) activity 
and dopamine (DA) concentrations were significantly depressed at all 
time points examined. Methamphetamine (17.5 mg/kg i.p.) administered 
to iprindo1e-treated rats, was required to produce a significant de-
crease in these parameters of the serotonergic and dopaminergic systems. 
Significant decreases were observed using doses of iprindo1e of 5 mg/kg 
and methamphetamine of 17.5 mg/kg. Iprindo1e alone produced a signif-
icant increase in TPH activity (to 138% of control) in the cerebral 
cortex after 1 day. After 3 days, cortical TPH activity had fallen to 
82% of control, whereas 5-HT and 5-HIAA were significantly increased 
over control. No effects were seen in the hippocampus, hypothalamus 
or neostriatum. Cloimipramine, amitriptyline and chlorpromazine also 
produced significant increases in cortical TPH activity 1 day after an 
injection of 10 mg/kg. This evidence suggests that, in the presence of 
a metabolic inhibitor, methamphetamine has neurotoxic effects similar 
to the halogenated amphetamines on the serotonergic system. These 
drugs produce a long-lasting decrease in TPH activity and 5-HT concen-
trations. Secondly, administration of iprindole alone, and possibly 
other antidepressant drugs, produces changes in TPH activity that 
reflect an ability to alter 5-HT biosynthesis independent of brain tryp-
tophan concentrations. 
Phencyclidine (PCP) was found to have little effect on the neo-
striatal serotonergic system; the only significant changes being an 
increase in 5-HIAA concentrations after 15 and 30 minutes. Cerebellar 
GAD activity was decreased 6 and 12 hours after 4 injections of PCP 
(10 mg/kg, i.p.) over 12 hours. This decrease was observed at a dose 
of 5 mg/kg. No changes were seen after either acute or chronic admin-
istration of the drug. These changes in cerebellar GAD activity may 
account for the convulsant activity of this abused drug. 
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INTRODUCTION 
The proliferation of data implicating a role for the catechola-
mines and indoleamines in the mediation of symptoms associated with 
schizophrenia has increased attention to developing animal models for 
this naturally occurring human disorder. Since these models may rep-
resent a simplified form of the complex human phenomena, they provide 
a method for the preclinical evaluation of drug treatments. It must 
be remembered that, at best, animal models reflect only a limited sub-
set of the symptoms associated with schizophrenia in humans. 
Presently, the most widely-used animal model for schizophrenia 
deals with the behavioral changes induced by catecholamine stimulants 
and by amphetamines in particular. It is well known that drugs such as 
amphetamine, methylphenidate, or L-dopa exacerbate the psychotic 
symptoms of a subset of schizophrenics (Angrist, Rotrosen and Gershon, 
1980 and Janowsky and Davis, 1976). Moreover, a high dose of ampheta-
mine or chronic abuse of this stimulant elicits psychotic symptoms 
among nonschizophrenic individuals (Segal and Janowsky, 1978 and Snyder, 
1973), and in the absence of a prior drug history these are often mis-
diagnosed as paranoid schizophrenics. The behavioral symptoms are 
distinguished by repetitive and compulsive behavior, hallucinations 
(auditory, visual and tactile), and delusions of persecution (Utena, 
1966; Kramer, Fischman and Littlefield, 1967 and Hofman, 1975). "Am-
phetamine psychosis" has a duration of approximately one week.· Residual 
behaviors have been reported to exist for several months (Kramer et al., 
2 
1967) to a year (Utena, 1966) after drug use. These include a loss of 
initiative and ability to concentrate, impairment of memory and apathy. 
Among non-human subjects, stimulant treatment elicits behaviors 
thought to reflect those observed among human drug abusers. Most 
importantly, these drugs cause stereotyped behaviors such as continuous 
sniffing, gnawing, grooming, and dyskinetic motor movements (Segal, 
1975). Since these behaviors are exacerbated by repeated drug admin-
istration and antagonized by drugs that have antipsychotic properties 
(Groves and Rebec, 1976), the amphetamine-induced stereotypies have 
been taken as an approximate comparison of human psychotic disorders. 
A consideration in evaluating the amphetamine model of schizo-
phrenia is the possible neurochemical interactions that subserve the 
syndrome. Amphetamine (and methamphetamine) produce neurochemical 
changes in the noradrenergic, dopaminergic and serotonergic systems of 
the rat brain. 
Koda and Gibb (1973), Buening and Gibb (1974) and Kogan, Nichols 
and Gibb (1976) showed that multiple toxic doses of methamphetamine 
caused a decrease in tyrosine hydroxylase (TH) activity, and dopamine 
(DA), and norepinephrine (NE) concentrations in the rat neostriatum. 
Morgan and Gibb (1980) showed that similar doses also decreased TH 
activity, and DA and NE concentrations in the olfactory tubercle but 
not in the other extrastriatal dopaminergic nuclei (nucleus accumbens 
and median eminence) examined. Furthermore, neostriatal and olfactory 
tubercle TH activities were significantly decreased up to 30 days 
after treatment with methamphetamine. 
The consequence of the administration of single doses of ampheta-
mine on DA metabolism are dose-dependent. Kuczenski (1980) has 
suggested that the following sequence of neuronal and biochemical 
events occurs in the nigrostriatal DA pathway with increasing doses 
(0.5 to greater than 2.0 mg/kg) of amphetamine: 
1) facilitated release of DA from striatal nerve 
endings with concomitant activation of DA synthesis; 
2) a release of DA from nigral DA dendrites leading 
to inhibition of firing in a subpopulation of nigro-
striatal neurons and accumulation of striatal DA; 
3) activation of a striato-nigral feedback pathway 
leading to inhibition of DA neuronal activity and at high 
doses; 
4) release of DA by amphetamine, independent of 
impulse flow, coupled with a blockade of DA reuptake and 
metabolism through extraneuronal monoamine oxidase. 
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Steranka and Sanders-Bush (1980) and Ellison, Eison, Huberman and 
Daniel (1978) have used either subcutaneously implanted minipumps or 
silicone pellets to examine the effects of continuously administered 
amphetamine. Ellison et al. (1978) found that TH activity was decreased 
in the neostriatum several days after implantation; enzyme activity 
had not returned to control values 110 days after pellet removal. TH 
activity was not decreased at 110 days if a dose of amphetamine equiv-
alent to that delivered from the silicone pellet was given by daily 
injection. Steranka and Sanders-Bush (1980) showed that 2 weeks after 
infusion of amphetamine for 3 days whole brain DA, but not 5-hydroxy-
tryptamine (5-HT) or NE, was decreased. These findings were in contrast 
to the results obtained after infusion of p-chloroamphetamine; which 
decreased brain 5-HT 2 weeks after infusion. Bakhit, Peat and Gibb 
(in press) found the neostriata1 enzyme activity was decreased 110 
days after repeated injections of methamphetamine. 
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Since an early report by Knapp, Mandell and Geyer (1974) of the 
effects of amphetamine on the serotonergic system in the rat brain, 
increasing attention has been paid to the effects of amphetamine and 
methamphetamine on this neurotransmitter system. Knapp et a1. (1974) 
~und that the acute administration of d- and l-amphetamine, methamphe-
tamine and p-ch1oroamphetamine reduced the conversion of tryptophan 
(Try) to 5-HT in striatal synaptosomes. Tryptophan hydroxylase (TPH) 
activity in the lateral midbrain was decreased; however, activity in 
the medial midbrain was unchanged. None of the amphetamines nor two 
major metabolites of amphetamine had a demonstrable effect on TPH 
activity in vitro. Hotchkiss and Gibb (1980) extended this work and 
showed that 12 hours after 4 doses of methamphetamine (15 mg/kg), neo-
striatal and hippocampal TPH activity were decreased to approximately 
10% of control and this depression persisted for at least 30 days. 
F1uoxetine, a selective 5-HT uptake inhibitor (Wong, Horng, Bymaster, 
Hauser and Molloy, 1974), blocked this decrease in TPH activity, but 
not the concomitant depression of neostriatal TH activity, suggesting 
that uptake of methamphetamine into the nerve terminal is required for 
its toxic effect on 5-HT synthesis. It has also been observed that 
fluoxetine prevents the neurotoxicity resulting from p-chloroamphetamine 
administration (Fuller, Perry and Molloy, 1975). 
Trulson and Jacobs (1979 a, 1979 band 1980), Ricaurte, Schuster 
and Seiden (1980) and Bakhit et al. (in press) have all reported effects 
of chronic methamphetamine or amphetamine on the serotonergic system. 
Trulson and Jacobs (1980) and Bakhit et al. (in press) found, in 
agreement with Hotchkiss and Gibb (1980), that TPH activity was de-
creased after multiple doses of amphetamines. All groups reported 
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that 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) were also decreased. 
In a similar fashion to the dopaminergic system, recovery in the 
serotonergic system was incomplete at 110 days after 4 repeated doses 
of methamphetamine (Bakhit et al., in press). Certain brain regions 
are also more sensitive to the effects of amphetamines, with cerebral 
cortex, hippocampus and striata being amongst the most sensitive and 
the hypothalamus being relatively resistant. This regional selectivity 
closely parallels the regional distribution of amphetamine as reported 
by Eison, Ellison and Eison (T98l). Both Bakhit et al. (in press) and 
Ricaurte et al. (1980) have suggested that the serotonergic systems of 
the rat brain are more sensitive than the dopaminergic ones to the 
apparent neurotoxic actions of methamphetamine. 
The acute effects of methamphetamine (or amphetamine) on the ser-
otonergic system have not been as extensively studied. Recent work in 
our laboratory has shown that cortical and neostriatal TPH activity 
are decreased 15 minutes after a single dose of methamphetamine (10 
mg/kg), whereas 5-HT concentrations are depressed at 30 minutes. No 
significant changes were seen in either neostriatal TH activity or DA 
concentrations. This work suggests that the primary action of meth-
amphetamine is to cause inhibition of TPH, and that the depletion of 
5-HT is secondary to this inhibition. This hypothesis is supported by 
the work of Trulson and Jacobs (1980) using the cnronic administration 
of amphetamine. 
It appears from the previous studies with amphetamine or meth-
amphetamine that both the dose of the drug and its persistence at the 
site of action are important for the apparent neurotoxic effects of 
these amphetamines. F~ller and Hemrick-Lueke (1980) have shown that 
neostriatal DA concentrations are decreased 7 days after the admini-
stration of amphetamine to iprindole-treated rats. Iprindole, an 
antidepressant drug, inhibits the hepatic metabolism and markedly in-
creases the brain half-life of amphetamine in the rat (Freeman and 
Sulser, 1972). Amfonelic acid, a DA uptake blocker (Shore, 1976), 
inhibited this effect of amphetamine in iprindo1e-treated rats which 
suggests that uptake of drug into the dopamine neuron is required for 
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the neurotoxic effect. The effects of combined administration of meth-
amphetamine and iprindole on the serotonergic system in the rat brain 
have not been reported. If long-lasting effects on this neurotransmitter 
system are observed, the neurotoxicity of this stimulant may be compar-
able to that observed with p-chloroamphetamine and fenf1uramine. 
Sanders-Bush, Busing and Sulser (1975) found that p-chloroampheta-
mine decreased 5-HT concentrations and TPH activity in several brain 
regions, with the hippocampus, cerebral cortex and neostriatum being 
particularly sensitive. As with methamphetamine, the hypothalamus was 
particularly resistant to the effects of p-chloroamphetamine: a de-
pression of cerebral cortical TPH activity and 5-HT and 5-HIAA concen-
trations was still observed 4 months after a single injection. Fen-
fluramine (21 mg/kg), another halogenated amphetamine, decreased 5-HT 
concentrations and TPH activity after 1 day, although the effects were 
greatly diminished 14 days later. Sanders-Bush et ale (1975) also 
reported a marked reduction in the high-affinity uptake of 5-HT by 
synaptosomes, which persists for several weeks after a single dose of 
p-ch10roamphetamine. Ricaurte et ale (1980) found a loss of 5-HT 
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synaptosomal uptake sites after both methamphetamine and p-chloroamphet-
amine administration. 
The primary aim of the research described in this thesis was to 
evaluate the combined effects of methamphetamine and iprindole on the 
serotonergic system in discrete nuclei of the rat brain. TPH and TH 
activity, DA, Try, 5-HT and 5-HIAA concentrations were determined by 
methods described °in the "Methods ll section. 
Recently, phencyclidine [l-(phenylcyclohexyl) piperidine or PCP] 
psychosis has been proposed as a drug model for acute schizophrenia 
(Allen and Young, 1978 and Meltzer and Stahl, 1976). PCP was origin-
ally employed as an anesthetic (Chen, Ensor, Russel and Bohner, 1959). 
Until recently it was used as a veterinary anesthetic. Because of its 
psychotomimetic properties, PCP is now widely abused for its mind-
altering effects. Prolonged toxic reactions to PCP ingestion, leading 
in many cases to hospital admission for schizophrenia-like psychoses 
(Allen and Young, 1978, Liden, Lovejoy and Costello, 1975 and Showalter 
and Thornton, 1977) are not uncommon. These toxic psychoses may last 
for as long as several weeks; this effect is probably due to accumula-
tion of the drug in adipose tissue and brain (Mishra, Pontani and 
Bartolomea, 1979). 
The toxic psychosis produced by PCP is similar to acute schizo-
phrenia in some respects such as its variable course and clinical 
picture, which may include catatonic, hebephrenic and paranoid features 
(Allen and Young, 1978). Because of these similarities, PCP psychosis 
has been proposed as a drug model for schizophrenia. While an under-
standing of the neuropharmacology of PCP has potential implications for 
schizophrenia research and treatment, the mechanisms underlying this 
drug-induced psychosis are poorly understood. 
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In rodents, low doses of PCP produce central stimulation charac-
terized by increased locomotor activity and stereotyped behavior, not 
unlike that caused by stimulants such as amphetamine (Sturgeon, Fessler 
and Meltzer, 1979). The effect of PCP on food-reinforced operant be-
havior is qualitatively similar to d-amphetamine (Wenger and Dews, 
1976). PCP induces ipsilateral turning in rats with unilateral elec-
trolytic or 6-hydroxydopamine-induced lesions in the nigrostriatal 
pathway, a finding consistent with an indirect rather than a direct DA 
agonist action (Fessler, Sturgeon and Meltzer, 1979). The fact that 
inhibition of DA synthesis with a-methylparatyrosine blocks this effect 
also suggests that PCP acts as an indirect DA agonist (Fessler et al., 
1979). 
Numerous reports indicate that PCP has important effects on central 
dopaminergic, noradrenergic, cholinergic, serotonergic, GABA-ergic and 
endogenous opiate transmitter systems (for review see Johnson 1978). 
Radioligand studies have indicated the existence of specific PCP re-
ceptors that may be relatively enriched in the hippocampus (Vincent, 
Karolovski, Geneste, Kamenka and Lazdunski, 1979 and Zukin and Zukin, 
1979). Recent work with the monoaminergic system has focused upon the 
effects of PCP on the noradrenergic and dopaminergic systems. 
Electrophysiological studies (Bickford, Palmer, Rice, Hoffer and 
Freedman, 1981 and Marwaha, Palmer, Woodward, Hoffer and Freedman, 1980) 
have concentrated upon the effects of PCP on noradrenergic transmission 
in the cerebellum and hippocampus. The results of the study on Pur-
kinje neurons in the cerebellum (Marwaha et al., 1980) suggested that 
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PCP acts by a presynaptic mechanism involving the release of NE from 
intact functioning noradrenergic terminals. Smith, Taylor, Ho and 
Leelavathi (1980) and Doherty, Somonovic, So and Meltzer (1980) have 
reported the effects of PCP on neostriatal dopaminergic metabolism. 
Smith et ale (1980) showed that a single dose (10 mg/kg) decreased 
neostriatal TH activity 15 minutes after administration; recovery was 
noted at 45 minutes. Chronic administration also decreased TH activity 
after 30 doses. Doherty et ale (1980) examined the effects of PCP on 
neostriatal 3,4-dihydroxyphenylalanine (DOPA) accumulation, after 
L-aromatic acid decarboxylase inhibition, and concentrations of DA and 
its metabolites; 3,4-dihydroxyphenyl acetic acid (DOPAC) and homovan-
illic acid (HVA). Their results suggested that the mechanism of 
action of PCP appears to be closely related to other non-amphetamine 
stimulants such as methylphenidate and amfonelic acid. In this regard, 
an early report by Smith, Meltzer, Arora and Davis, (1977) demonstrated 
that PCP was similar in potency to d-amphetamine and methylphenidate 
in inhibiting catecholamine ([3H]-NE and [3H]-DA) uptake in synaptosomal 
preparations. The same group also showed that PCP was considerably 
more potent than either amphetamine or methylphenidate in inhibiting 
[3H]-5-HT uptake. 
Although it is postulated that the dopaminergic and noradrenergic 
systems are both involved in the manifestation of the symptoms of 
schizophrenia; the evidence obtained using amphetamine (or methampheta-
mine) administration as a model for schizophrenia also suggests that 
the serotonergic system is involved. If this is so, then the animal 
model produced by PCP administration may also reflect changes in the 
serotonergic system. A secondary aim of the research described in this 
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thesis was to examine the effects of PCP on the serotonergic system in 
discrete nuclei of the rat brain, and to observe any neurochemical 
similarities between these and those of methamphetamine. 
METHODS 
Animals 
Male, Sprague-Dawley rats weighing 200-300 gm were used for all 
experiments. The animals were housed 3 to 5 per cage with constant 
access to food and water. A l2-hour light-dark cycle (6:00 am - 6:00 
pm) was maintained in the animal quarters. 
Drug Administration 
All drugs were administered in 0.9% saline by i.p injection. 
Saline was used to inject control animals. The following dosage sched-
ules were used for the experiments: 
1) Methamphetamine was administered 2 hours after a single injec-
tion of iprindole. The exact doses used are shown in the appropriate 
Table or,Figure legends. Rats were sacrificed 1, 3, 7 and 14 days after 
the injection of methamphetamine to iprindole-treated rats. 
2) For the experiments involving iprindole alone, animals were 
sacrificed 2, 6, 24 hours, 3 and 7 days after a single i.p. injection 
(10 mg/kg). For experiments involving other antidepressants, animals 
were sacrificed 24 hours after a single i.p. injection (10 mg/kg). 
3) Experiments involving PCP were carried out using 3 different 
dosing schedules: 
a) Rats were sacrificed at a number of time points 
between 15 and 120 minutes after a single injection of PCP 
(10 mg/kg). 
b) Rats were sacrificed at a number of time points 
between 1 and 24 hours following 4 injections of PCP at 
3-hour intervals over a period of 12 hours. 
c) Rats were sacrificed 15 minutes and 24 hours after 
30 daily injections of PCP (10 mg/kg). 
Brain Dissection 
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All animals were sacrificed between 9:00 am and 4:00 pm to avoid 
diurnal rhythms in enzyme activities and neurotransmitter concentra-
tions. Brains were rapidly removed and neostriata, cerebral cortex, 
hippocampus, hypothalamus and cerebellum dissected out and frozen 
separately on dry ice. Tissues were stored at -70° until analysis. 
Tryptophan Hydroxylase Assay 
Tissues were homogenized separately in 50 mM HEPES buffer (Sigma), 
pH 7.4, containing 0.2% Triton X-100 and 5 mM dithiothreitol, and cen-
trifuged for 15 minutes at 19,000 X g. Duplicate 7.5-~1 aliquots of 
the supernatant were assayed for TPH activity by the method of Ichiyama 
et al. (1970) as described by Sitaram and Lees (1978). The final con-
centrations of the reactants were as follows: HEPES, 50 mM, pH 7.4 at 
25°C; L- (12C) - tryptophan, 0.1 mM, L- (l~C) - tryptophan, 0.02 mM 
(10 nCi) and hog kidney L-aromatic acid decarboxylase in excess. The 
final reaction mixture (12.5 ~l) was contained in a 6 x 50 mnl silanized 
glass tube. A 1~C02 trapping tube of the same size contained an 8 x 15-
mm piece of filter paper wetted with 50 ~l hyamine hydroxide (1.0 M in . 
methanol; Sigma). The reaction tube and trapping tube were joined with 
a 5-cm piece of tightly fitting rubber tubing and incubated at 37°C for 
30 minutes. The reaction was terminated by the injection of 100 ~l of 
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5 N sulfuric acid into the reaction tube, and then incubated an addi-
tional 90 minutes at 37°C to complete the trapping of CO 2 , The filter 
paper was then transferred to a scintillation vial and the trapping 
tube rinsed with 4 ml of scintillation cocktail. The combined rinse 
and filter paper were counted by liquid scintillation spectroscopy with 
a counting efficiency of 90-95%. 
Tyrosine Hydroxylase and Tryptophan Hydroxylase Assays 
Aliquots of the same neostriatal homogenate were analyzed concur-
rently for TH and TPH activities. Tissues were homogenized in 4 vol-
umes of 50 mM HEPES buffer (Sigma), pH 7.4, containing 0.2% Triton 
X-100 and 5 mM dithiothreitol and centrifuged for 15 minutes at 
19,000 X g. Duplicate 7.5-~1 aliquots of the supernatant were added 
to 42.5 ~l of double distilled water and assayed for TH activity 
according to the method of Nagatsu et al. (1964). TPH activity was 
determined as previously described. 
Glutamic Acid Decarboxylase Assay 
Glutamic acid decarboxylase (GAD) activity was determined by a 
modification of the method of Albers and Brady (1959). In brief, 
tissues were homogenized in 24 volumes 0.2% Triton X~lOO containing 
1 mg/ml bovine serum albumin (BSA) and 4 mM dithiothreito1. After 
centrifugation for 15 minutes at 19,000 X g, 10 ~l of the supernatant 
were added to 10 ~l reaction mixture containing (final concentration) 
38 mM potassium phosphate buffer, pH 6.5; 12 mM sodium glutamate, 
pH 6.5; 0.2 mM pyridoxal phosphate; 1 mM potassium chloride; 0.1% 
Triton X-100; 0.05 mg/ml BSA; 2 mM dithiothreitol and 0.1 ~Ci l-L-14C 
glutamic acid. Labelled CO 2 was trapped on filter paper soaked with 
14 
hyamine hydroxide (1.0 M in methanol) and counted via liquid scintil-
lation spectroscopy. 
Determination of Indoleamines, Dopamine and Norepinephrine 
In order to quantitate 5-HT, 5-HIAA, Try, DA and NE in discrete 
brain regions it was necessary to develop a high performance liquid 
chromatographic (HPLC) procedure using fluorometric detection (Peat 
and Gibb, submitted). All determinations were performed using a model 
5020 solvent delivery system (Varian Instrument) with a loop injector 
(Valco Instrument Co.) and a model 650 fluorometer equipped with an 
l8-~1 flow cell (Perkin Elmer Corpo). The excitation wavelength was 
set at 290 nrn and the emission at 330 nm, the detector signal was re-
corded on a Linear recorder (10 mV input). An Ultrasphere-ODS reversed 
phase column (5 ~m particle size range); 150 x 4.6 mm id (Altex 
Scientific) was used. The mobile phase was prepared with potassium 
phosphate monobasic (0.02 M) containing 1 gm per liter of heptane sulf-
onic acid sodium salt, adjusted to a pH of 3.3 using phosphoric acid, 
and a mixture of methanol: double distilled deionized water (3:2). 
Thirty-four percent of the organic modifier was used. 
A stock solution of indo1eamines and catecholamines in 0.1 M 
perchloric acid containing 4 mM sodium metabisulfite was prepared. 
This contained 0.1 mg/ml of 5-HT, 0.1 mg/ml of 5-HIAA, 0.5 mg/ml of 
Try, 0.25 mg/ml of DA and 0.1 mg/ml of NE. Aliquots (100 ~l) of this 
stock solution were stored at -15°C and were used to prepare standard 
solutions as shown in Table 1. 
15 
TABLE 1 
PREPARATION OF STANDARDS 
(ng/lJl) 
Solution Dilution 5-HT 5-HIAA Try DA NE 
A lin 100 stock 1.0 1.0 5.0 2.5 1 .0 
B lin 4A 0.25 0.25 1.25 0.625 0.25 
C lin lOA o. 1 o. 1 0.5 0.25 O. 1 
0 lin 2C 0.05 0.05 0.25 0.125 0.05 
E lin SA 0.2 0.2 0.5 0.2 
Dilutions were made with the perchloric acid solution. Before 
use, all solutions were protected from light. Standards A-E must be 
made during each set of analyses. 
Bra;n regions were homogenized in 0.1 M perchloric acid containing 
4 mM sodium bisulfite. The amount of acid used for homogenization 
depended upon the amount of tissue available; for example 10 mg of 
neostriatum were homogenized in 100 lJl of acid and cerebral cortex 
(50 mg) in 500 lJl of solution. After homogenization, the extract was 
centrifuged at 19,000 x g for 15 minutes. Fifty lJl of the supernatant 
were then injected via a 50-lJl sample loop directly onto the HPLC 
column. All of the procedures, before injection, were carried out at 
4°C and the extracts protected from light. 
The concentration of each of the compounds in brain tissue was 
determined from the chromatographic peak heights. Calibration curves 
were constructed by injecting standard solutions B-E and plotting the 
amount of compound against peak heights. 
16 
Table 2 lists the retention volumes of the compounds examined 
using this system. Metabolites of dopamine and norepinephrine were not 
detectable under the fluorescent conditions chosen for the assay. 
TABLE 2 
RETENTION VOLUMES OF SOME INDOLEAMINES AND CATECHOLAMINES 










Sensitivity of the assay for 5-HT, 5-HIAA, NE, DA and Try was de-
termined by injecting known amounts of each compound in perchloric acid 
solution. At excitation and emission wavelengths of 290 and 300 nm 
respectively, sensitivity was greatest for 5-HT and decreased in the 
following order: 5-HT > 5-HIAA > NE > DA > Try. The limits of sensi-
tivities (signal to noise 3:1) were found to be 1.1 pmoles for 5-HT, 
2.0 pmoles 5-HIAA, 3.0 pmoles NE, 4.9 pmoles DA and 6.1 pmoles Try. 
Linearity of the detector was found to be satisfactory for standards B 
through E (Table 1). Within-run precision studies for all five com-
pounds gave a coefficient of variation of less than 8%. 
RESULTS 
Effects of Methamphetamine and Iprindole 
Figures 1 to 3 illustrate the effects of consecutive doses of 
iprindole (10 mg/kg) and methamphetamine (17.5 mg/kg) on TPH activity, 
5-HT and 5-HIAA concentrations at 4 time points (1, 3, 7 and 14 days) 
after injection in the cerebral cortex, neostriatum and hypothalamus. 
Previous studies (Bakhit et al., in press and Ricaurte et al., 1980) 
have shown that the cortex and neostriatum are particularly sensitive 
to the effect of methamphetamine whereas the hypothalamus is relatively 
resistant. Significant decreases were observed in TPH activity and 5-HT 
concentrations in the brain regions examined at 3 and 7 days with the 
maximum depression in enzyme activity and indoleamine concentrations seen 
3 days after injection. Although neostriatal and cortical enzyme activ-
ities were decreased at 14 days (by 23 and 25% respectively), hypothal-
amic activity had returned to control values; this was in contrast to 
indoleamine concentrations which were still significantly depressed. 
TPH activities were decreased in the cortex (by 44%), neostriatum 
(by 46%) and in the hypothalamus (by 44%) 1 day after the administration 
of methamphetamine to iprindole-treated rats. This was in contrast to 
indoleamine (5-HT and 5-HIAA) concentrations which were not signifi-
cantly different from control values. Different effects were observed 
in the neostriatal dopaminergic system (Figure 4); TH activity and DA 
concentrations 1 day following treatment were decreased by 31% and 35%, 
respectively. In a similar fashion to the neostriatal serotonergic 
FIG. 1 Effect of methamphetamine (METH) and iprindole (IPR) on TPH 
activity, 5-HT and 5-HIAA concentrations in the cerebral cortex at 
1,3, 7 and 14 days after injection. Rats were injected with either 
saline/METH (--), IPR/sa1ine (- . -) or IPR/METH (---). IPR 
(10 mg/kg) or saline were administered 2 hours before injection of 
METH (17.5 mg/kg) or saline. The number of animals per group were 
4 or more. Brackets indicate + S.E.M. Control values were 
25.9 + 1.1 nmo1es Try oxidized/gm tissue/hr (n = 16), 0.21 ~ 0.009 
5-HT ng/mg tissue (n = 16) and 0.14 ~ 0.006 5-HIAA ng/mg tissue 
(n = 16). 
(*) P <0.05 compared to saline/saline control 
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FIG. 2 Effect of METH and IPR on TPH activity, 5-HT and 5-HIAA 
concentrations in the hypothalamus at 1,3,7 and 14 days after 
injection. Rats were injected with either saline/METH (--), 
IPR/sa1ine (- · -) or IPR/METH (---). IPR (10 mg/kg) or saline 
were administered 2 hours before injection of METH (17.5 mg/kg) or 
saline. The number of animals per group were 4 or more. Brackets 
indicate + S.E.M. Control values were 107 ~ 5.5 nmo1es Try oxidized/ 
gm tissue/hr (n = 16), 0.76 ~ 0.03 5-HT ng/mg tissue (n = 16) and 
0.60 ~ 0.04 5-HIAA ng/mg tissue (n = 16). 
(*) p < 0.05 compared to saline/saline control 
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FIG. 3 Effect of METH and IPR on TPH activity, 5-HT and 5-HIAA 
concentrations in the neostriatum at 1, 3,7 and 14 days after injec-
tion. Rats were injected with either saline/METH (--), IPR/sa1ine 
(- · -) or IPR/METH (---). IPR (10 mg/kg) or saline were admini-
stered 2 hours before injection of METH (17.5 mg/kg) or saline. The 
number of animals per group were 4 or more. Brackets indicate + S.E.M. 
Control values were 24.2 ~ 1.3 nmoles Try oxidized/gm tissue/hr (n = 
16), 0.81 ~ 0.04 5-HT ng/mg tissue (n = 16) and 0.60 + 0.03 5-HIAA 
ng/mg tissue (n = 16). 
(*) P <0.05 compared to saline/saline control 
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FIG. 4 Effect of METH and IPR on TH activity and DA concentrations in 
the neostriatum at 1,3,7 and 14 days after injection. Rats were in-
jected with either saline/METH (--), IPR/saline (- . -) or IPR/METH 
(---). IPR (10 mg/kg) or saline were administered 2 hours before 
injection of METH (17.5 mg/kg) or saline. The number of animals per 
group were 4 or more. Brackets indicate + S.E.M. Control values were 
1550 + 96 nmoles tyrosine oxidized/gm tissue/hr (n = 16), and 9.4 ~ 0.4 
DA ng/mg tissue (n = 16). 
(*) P < 0.05 compared to saline/saline control 
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system, decreases were seen in both TH activity and DA concentrations 
at 3, 7 and 14 days. 
Enzyme activities (TPH and TH), 5-HT, 5-HIAA and DA concentrations 
were monitored (Figures 1-4) after the injection of iprindole or meth-
amphetamine alone. The latter agent decreased neostriatal TH activity 
and DA concentrations 1 day after a single injection of 17.5 mg/kg; no 
changes were observed at 3, 7 or 14 days after injection (Figure 4). 
TPH activity and indoleamine concentrations, with the exception of 
neostriatal 5-HT and 5-HIAA concentrations after 3 days (Figure 3), 
were not significantly different from control values at any time point 
after a single injection of methamphetamine in the brain regions exam-
ined. 
Administration of iprindole alone caused changes in cortical TPH 
activity and indoleamine concentrations 1 and 3 days after injection 
(Figure 1). Enzyme activity was significantly increased (by 62%) at 
1 day and decreased (by 18%) at 3 days; recovery was observed at 7 
days. Cortical 5-HT concentrations were increased after 1 day (by 23%); 
however, in contrast to the enzyme activity, they were still signifi-
cantly elevated at 3 days (by 31%). 5-HIAA concentrations were only 
significantly higher than control values at 3 days. Administration of 
iprindole alone did not cause any significant changes in the seroton-
ergic system of the neostriatum (Figure 3) or hypothalamus (Figure 2) 
nor in the neostriatal dopaminergic system (Figure 4). 
To determine whether lower doses of methamphetamine administered 
to iprindole-treated rats would produce similar effects in regional 
serotonergic and neostriatal dopaminergic systems, methamphetamine 
doses of 2.5, 7.5, 10, 12.5 and 17.5 mg/kg were administered to rats 
27 
given 10 mg/kg of iprindo1e 2 hours previously. The animals were sac-
rificed at 7 days. Figures 5 to 8 show the effects of increasing doses 
of methamphetamine on cortical, hypothalamic and neostriata1 parameters. 
Although effects were observed at 10 and 12.5 mg/kg in the cerebral 
cortex and hypothalamus, significant changes in all 3 brain regions 
examined were only seen at 17.5 mg/kg. 
Freeman and Sulser (1972) had shown that a single dose of iprindo1e 
(10 mg/kg) inhibited the para-hydroxylation of amphetamine in the rat. 
This finding was used by Fuller and Hemrick-Lueke (1980) to show that 
7 days after the injection of amphetamine to iprindo1e-treated rats, 
cerebral hemisphere and neostriata1 DA concentrations were still signif-
icantly decreased. The possibility was investigated that a lower dose 
of this metabolic inhibitor would produce a similar effect. Figures 
9 to 12 show the results of experiments using a fixed dose of meth-
amphetamine (17.5 mg/kg) and varying doses of iprindo1e. Animals were 
sacrificed 7 days after injection. Doses of iprindo1e of 5 and 10 mg/kg 
resulted in decreases in TPH activity, 5-HT and 5-HIAA concentrations 
in all regions examined (Figures 9-11). In addition, neostriatal TH 
activity and DA concentrations were decreased (Figure 12). Although 
a dose of 2 mg/kg also led to a reduction in these parameters, these 
were only of statistical significance for cortical TPH activity and 
neostriata1 TPH and TH activities. 
The effect of iprindo1e on cortical TPH activity after 24 hours 
was unexpected. Neckers, Biggio, Moja and Meek (1977) reported that 
treatments lowering brain Try concentrations increased TPH activity and 
this appeared to be related to an increase in the Vmax of the enzyme. 
More specifically, they reported that a single dose of c10imipramine 
FIG. 5 Effect of varying doses of METH and a fixed dose of IPR 
(10 mg/kg) on TPH activity, 5-HT and 5-HIAA concentrations in the 
cerebral cortex. Animals were sacrificed 7 days after the injection 
of METH to IPR treated rats. The number of animals per group were 4 
or more. Brackets indicate + S.E.M. Control values were 28.7 + 3.0 
nmoles Try oxidized/gm tissue/hr (n = 6), 0.39 ~ 0.03 5-HT ng/mg 
tissue (n = 5) and 0.26 ~ 0.02 5-HIAA ng/mg tissue (n = 5). 
(*) p < 0.05 compared to saline control 
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FIG. 6 Effect of varying doses of METH and a fixed dose of IPR 
(10 mg/kg) on TPH activity, 5-HT and 5-HIAA concentrations in the 
hypothalamus. Animals were sacrificed 7 days after the injection of 
METH to IPR treated rats. The number of animals per group were 4 or 
more. Brackets indicate + S.E.M. Control values were 96 + 6 nmoles 
Try oxidized/gm tissue/hr (n = 5), 0.84 + 0.06 5-HT ng/mg tissue 
(n = 5) and 0.63 ~ 0.05 5-HIAA ng/mg tissue (n = 5). 
(*) p < 0.05 compared to saline control 
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FIG. 7 Effect of varying doses of METH and a fixed dose of IPR 
(10 mg/kg) on TPH activity, 5-HT and 5-HIAA concentrations in the 
neostriatum. Animals were sacrificed 7 days after the injection of 
METH to IPR treated rats. The number of animals per group were 4 or 
more. Brackets indicate + S.E.M. Control values were 24.4 + 2.8 
nmoles Try oxidized/gm tissue/hr (n = 5), 0.86 ~ 0.06 5-HT ng/mg 
tissue (n = 6) and 0.52 ~ 0.04 5-HlAA ng/mg tissue (n = 6). 
(*) p < 0.05 compared to saline contr01 
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FIG. 8 Effect of varying doses of METH and a fixed dose of IPR 
(10 mg/kg) on TH activity and DA concentrations in the neostriatum. 
Animals were sacrificed 7 days after the injection of METH to IPR 
treated rats. The number of animals per group were 4 or more. 
Brackets indicate + S.E.M. Control values were 1985 + 158 nmo1es 
tyrosine oxidized/gm tissue/hr (n = 6) and 9.2 + 1.0 DA ng/mg tissue 
(n = 6). 
(*) p < 0.05 compared to saline control 
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FIG. 9 Effect of varying doses of IPR and a fixed dose of METH 
(17.5 mg/kg) on TPH activity, 5-HT and 5-HIAA concentrations in the 
cerebral cortex. Animals were sacrificed 7 days after the injection 
of METH to IPR treated rats. The number of animals per group were 
4 or more. Brackets indicate + S.E.M. Control values were 20.8 + 0.9 
- -
nmoles Try oxidized/gm tissue/hr (n = 5), 0.23 ~ 0.01 5-HT ng/mg 
tissue (n = 6) and 0.14 ~ 0.01 5-HIAA ng/mg tissue (n = 5). 
(*) p < 0.05 compared to saline control 
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FIG. 10 Effect of varying doses of IPR and a fixed dose of METH 
(17.5 mg/kg) on TPH activity, 5-HT and 5-HIAA concentrations in the 
hypothalamus. Animals were sacrificed 7 days after the injection of 
METH to IPR treated rats. The number of animals per group were 4 or 
more. Brackets indicate ~ S.E.M. Control values for TPH activity 
were 119 ~ 8 nmoles Try oxidized/gm tissue/hr (n = 6),1.1 + 0.1 
5-HT ng/mg tissue (n = 6) and 0.73 ~ 0.04 5-HIAA ng/mg tissue (n = 6). 
(*) p < 0.05 compared to sal i ne control 
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FIG. 11 Effect of varying doses of IPR and a fixed dose of METH 
(17.5 mg/kg) on TPH activity, 5-HT and 5-HlAA concentrations in the 
neostriatum. Animals were sacrificed 7 days after the injection of 
METH to IPR treated rats. The number of animals per group were 4 or 
more. Brackets indicate + S.E.M. Control values were 28.1 + 2.2 
nmoles Try oxidized/gm tissue/hr (n = 4), 0.53 ~ 0.04 5-HT ng/mg 
tissue (n = 4) and 0.4 ~ 0.03 5-HlAA ng/mg tissue (n = 4). 
(*) p < 0.05 compared to saline control 
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FIG. 12 Effect of varying doses of IPR and a fixed dose of METH 
(17.5 mg/kg) on TH activity and DA concentrations in the neostriatum. 
Animals were sacrificed 7 days after the injection of METH to IPR 
treated rats. The number of animals per group were 4 or more. 
Brackets indicate + S.E.M. Control values were 1716 + 145 nmoles 
tyrosine oxidized/mg tissue/hr (n = 4) and 8.9 + 0.9 DA ng/mg tissue 
(n = 4). 
(*) p < 0.05 compared to saline control 


























(15 mg/kg) led to an activation of TPH and a decreased Try content in 
the rat forebrain as early as 15 m-inutes after injection. This effect 
was still present after 4 hours. More recently Badawy and Evans (1981) 
have shown that rat liver tryptophan pyrrolase is decreased 2 hours 
after the administration of a single dose (10 mg/kg) of several anti-
depressants. More particularly, they reported that iprindole increased 
brain Try concentrations and that desipramine increased brain 5-HT, 
5-HlAA and Try. Chlorpromazine was shown to be ineffective. 
Iprindole, desipramine and cloimipramine are all used clinically 
as antidepressants. Until recently, it was believed that these drugs 
acted by inhibiting the reuptake of neurotransmitters (5-HT and NE), 
thereby increasing their concentration in the synapse. However, this 
theory has been questioned, in part, because there are a number of 
therapeutically useful agents which are not efficient uptake blockers. 
Iprindole is an exa.mple of one of these "atypical antidepressants. 1I 
To examine further the effects of iprindole on the serotonergic 
system in the rat brain, experiments were carried out using a single 
dose of 10 mg/kg. Figure 13 shows the time-course of its effects on 
cortical TPH activity, 5-HT and 5-HIAA concentrations. TPH activity 
was increased to 138% of saline control at 1 day and then fell to 82% 
of control at 3 days. Although there appeared to be an apparent in-
crease in 5-HT and 5-HIAA concentrations at 1 day, this only reached 
significance at 3 days. After 7 days, all 3 parameters had returned 
to control values. No significant changes were seen at time points 
(2 and 6 hours) earlier than 24 hours nor in cortical Try concentra-
tions at any of the time points, except for an increase in Try 
concentrations at 7 days (saline 4.7 ~ 0.27 ng/mg tissue, iprindole 
6.i ~ 0.23 ng/mg tissue). 
FIG. 13 Effect of a single dose of IPR (10 mg/kg) on TPH activity, 
s-HT and s-HIAA concentration at 2 hours, 6 hours, 1 day, 3 days and 
7 days in the cerebral cortex. The number of animals per group were 
4 or more. Brackets indicate + S.E.M. Control values were 24.6 + 1.4 
nmoles Try oxidized/gm tissue/hr (n = 26), 0.23 ~ 0.02 s-HT ng/mg 
tissue (n = 28) and O. 18 ~ 0.01 s-HIAA ng/mg tissue (n = 28). 
(*) p < 0.05 compared to sal ine control 
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Tables 3 and 4 show the effects of iprindo1e 2, 6 and 24 hours 
after injection on TPH activity, indo1eamine and Try concentrations in 
the hippocampus, hypothalamus and neostriatum and on neostriata1 TH 
activity and OA concentrations. No significant changes in these para-
meters were observed in any of the brain regions examined. It appears, 
therefore, from these initial studies that the effects of iprindo1e on 
the serotonergic system are limited to the cortex and do not result 
from changes in cortical Try concentrations. 
Table 5 details the effects of several drugs (iprindole, chlor-
promazine, amitriptyline, cloimipramine, fluoxetine and desipramine) 
on cortical TPH activity, indo1eamine and Try concentrations. Three 
drugs, (cloimipramine, amitriptyline and chlorpromazine) all increased 
TPH activity and 5-HT concentrations, in a similar manner to iprindo1e. 
Cloimipramine and chlorpromazine also increased 5-HIAA concentrations. 
Although desipra.mine did not increase TPH activity, 5-HT and 5-HIAA 
concentrations were significantly elevated. The only agent to affect 
Try concentration was cloimipramine, which increased it significantly 
by 29%; this is in contrast to the results reported by Neckers et a1. 
(1977) and Badawy and Evans (1981), although neither group monitored 
the amino acid concentrations at 24 hours. 
Effects of Phencyclidine 
The primary aim of the study with PCP was to compare its effects 
on the neostriatal serotonergic system of the rat brain with meth-
amphetamine-induced changes. Acute and chronic injection of meth-
amphetamine have been shown to decrease neostriatal TPH activity and 
5-HT concentrations. After an acute injection of methamphetamine 
48 
TABLE 3 
TPH ACTIVITY, 5-HT, 5-HIAA AND Try CONCENTRATIONS IN THE 
HIPPOCAMPUS, HYPOTHALAMUS AND NEOSTRIATUM AFTER A 
SINGLE INJECTION OF IPR (10 mg/kg) 
(Expressed as % of Control) 
Hours 
2 6 24 
n x + S.E.M. n x + S.E.M. n x + S.E.M. 
HiEEocamEus 
TPH 6 97 + 9.4 6 106 +8.9 5 92 + 4.3 
5-HT 6 95 + 5.2 6 93 + 6.2 6 115 + 4.8 
5-HIAA 6 89 + 5.6 6 100 + 4.5 6 106 + 3.2 
Try 6 98 + 6.2 6 94 + 3.6 6 103 + 2.6 
HlEotha1amus 
TPH 6 92 + 4.5 6 100 + 7.7 6 101 + 11 
5-HT 5 98 + 2.3 5 68 + 14 6 85 + 5 
5-HIAA 5 101 + 4.3 5 107 + 15 6 87 + 5.9 
Try 5 105 + 7.8 5 93 + 10 5 96 + 6.2 
Neostriatum 
TPH 4 88 + 3.5 5 111 + 9.4 6 82 + 17 
5-HT 5 93 + 5.2 6 107 + 9.3 6 104 + 7.0 
5-HIAA 6 92 + 6.2 6 115 + 7.6 6 113 + 6.1 
Try 6 97 + 7.1 6 102 + 11 6 124 + 4.2 
Control values were as follows: h"ippocampus; 31.9 + 1.3 nmo1es Try 
oxidized/gm tissue/hr (n = 16), 0.40 + 0.014 5-HT ng/mg tissue 
(n = 17), 0.45 + 0.013 5-HIAA ng/mg tTssue (n = 17) and 4.8 + 0.5 
Try ng/mg tissue (n = 17); hypothalamus, 69.2 + 4.3 nmoles Try 
oxidized/gm tissue/h'r (n = 16), 0.63 + 0.05 5-HT ng/mg tissue (n = 
17), 0.31 + 0.015 5-HIAA ng/mg tissue-(n = 17) and 3.6 + 0.7 Try 
ng/mg tissue (n = 17); neostriatum, 27.8 + 2.6 nmo1es Try oxidized/ 
gm tissue/hr (n = 16), 0.40 ! 0.039 5-HT ng/mg tissue (n = 16), 
0.35 + 0.02 5-HIAA ng/mg tissue (n = 16) and 3.42 + 0.27 Try ng/mg 






























































































































































































































































































































































































































































































































































































































































































































(10 mg/kg) a decrease in enzyme activity is observed after 15 minutes; 
however, 5-HT concentrations are not significantly lowered until 30 
minutes. Subacute administration of methamphetamine has also been 
shown to decrease neostriatal TPH activity, 5-HT and 5-HIAA concentra-
tions (Bakhit et a1., in press). 
Initial experiments, involving the subacute administration of PCP 
(see Methods) showed no statistical difference between neostriatal 
indoleamine concentrations of treated and saline control animals (Table 
6). Smith et al. (1980), however, had reported that neostriatal TH 
activity was decreased 15 minutes after an acute injection of PCP 
(10 mg/kg) and 15 minutes and 24 hours after 30 daily injections. For 
this reason, neostriatal 5-HT and 5-HIAA concentrations were monitored 
after both chronic and acute administration of the drug. Table 7 shows 
the results of the chronic study; no statistical difference was observed 
in either parameter. The effects of an acute injection of PCP on neo-
striatal indoleamine concentrations are shown in Figure 14. When com-
pared to their own saline control, 5-HIAA concentrations were signifi-
cantly elevated at 15 and 30 minutes, but not at any other time point 
examined (10, 20, 60 and 120 minutes). 5-HT concentrations were not 
significantly different from saline controls at any time point examined. 
It is interesting to note that there appears to be a cyclical variation 
in both 5-HT and 5-HIAA concentrations between 15 and 30 minutes. It 
is clear, from these limited studies, that although PCP may have a 
subtle effect on the neostriata1 serotonergic system, it does not cause 
the same dramatic effects as methamphetamine administration. 
The effects of PCP on glutamic acid decarboxylase (GAD) activity 
were also examined. Acute and chronic injections of the drug produced 
FIG. 14 Time-course of the effects of a single injection (10 mg/kg) 
of phencyclidine (PCP) on 5-HT (- -) and 5-HIAA (---) concentrations 
in the neostriatum. The number of animals per group were 5 or more. 
Brackets indicate + S.E.M. Control values were 1.08 + 0.08 5-HT 
- -
ng/mg tissue (n = 30) and 0.85 ~ 0.06 5-HIAA ng/mg tissue (n = 30). 
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no significant changes in enzyme activity in any of the regions exam-
ined (Table 8); however, subacute administration of 10 mg/kg every 3 
hours for 12 hours resulted in a 16% decrease of cerebellar GAD activity 
12 hours after the last injection. No changes were seen in hippocampal, 
cortical or neostriatal enzyme activity (Table 9). Figure 15 shows a 
dose-response curve for the decrease in cerebellar enzyme activity. 
Although doses of 1 and 2.5 mg/kg produced no statistically significant 
decrease, enzyme activity was depressed after doses of 5 and 10 mg/kg. 
The time-course of this depression was monitored by sacrificing animals 
at various times after the subacute administration of 10 mg/kg of PCP. 
Figure 16 details the results of this experiment. GAD activity was 
only significantly decreased 6 and 12 hours after the last injection. 
FIG. 15 Dose response for the effects of subacute administration of 
PCP on GAD activity in the cerebellum. Animals were sacrificed 12 
hours after the last injection. The number of animals per group were 
9 or more. Brackets indicate + S.E.M. Control value was 4717 + 235 
nmoles glutamate oxidized/gm tissue/hr (n = 9). 
(*) p < 0.05 compared to sa 1 ine control 
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FIG. 16 Time-course of the effects of subacute administration of PCP 
(10 mg/kg) on GAD activity in the cerebellum. The number of animals 
per group were 4 or more. Brackets indicate + S.E.M. Control value 
was 3498 ± 71 nmoles glutamate oxidized/gm tissue/hr (n = 22). 
















6 12 24 
HOURS AFTER LAST INJECTION 
TABLE 8 
EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF PCP ON GAD ACTIVITY 
IN THE CEREBELLUM AND CEREBRAL CORTEX 
(Expressed as % of Control) 
Cerebellum Cerebra 1 Cortex 
n x ± S.E.M. n x + S.E.M. 
Acute: 
10 Mi ns 4 104 + 4.3 6 113 + 5.9 
15 Mins 6 98 + 5. 1 4 118 + 8. 1 
20 Mins 6 120 + 6.8 4 108 + 4. 1 
30 Mins 5 96 + 2.0 4 110 + 6.9 
60 Mins 5 108 + 3.5 6 96 + 6.3 
120 Mins 5 110 + 0.9* 6 91 + 3.2 
Chronic: 
15 Mi ns 10 109 + 11 10 101 + 4.7 
24 Hrs 9 80 + 19 9 96 + 3.2 
For the acute group, animals were administered 10 mg/kg of PCP or 
saline and sacrificed at the time points shown. 
For the chronic group, animals were sacrificed 15 minutes and 24 
hours after 30 daily injections of PCP (10 mg/kg) or saline. 
Control GAD activities (nmoles glutamate oxidized/gm tissue/hour) 
were as follows: Cerebellum 3399 + 266 (n = 40) and cerebral 
cortex 8342 ~ 341 (n = 40). 



















































































































































































































































































In the present study, the effects of a combined dose of iprindole 
and methamphetamine on the serotonergic system in the neostriatum, 
cerebral cortex and hypothalamus and on the dopaminergic system in the 
neostriatum were examined. Freeman and Sulser (1972) have previously 
shown that tprindole inhibited the para-hydroxylation of amphetamine in 
the rat, increasing the brain half-life of amphetamine 4 to 5 fold. 
Inhibition of methamphetamine metabolism by iprindole would therefore 
lead to a prolongation of its activity. The results of combined admin-
istration show that 14 days after administration, cortical (Figure 1) 
and neostriatal (Figure 3) TPH activity were still significantly de-
creased. These decreases in enzyme activity correlated well with de-
creases in indoleamine concentrations. In contrast, hypothalamic indol-
eamine concentrations were still depressed after 14 days but TPH activity 
had returned to control values (Figure 2). Previous work (Bakhit et al., 
in press) has shown that the hypothalamic serotonergic system is rela-
tively resistant to the effects of methamphetamine; recovery in enzyme 
activity and indoleamine concentrations was observed 110 days after the 
subacute administration of methamphetamine. Ricaurte et al. (1980) also 
showed that methamphetamine treatment decreased the concentration of 
5-HT in several brain regions and that the same treatment reduced the 
number of 5-HT uptake sites. It is possible that recovery in hypothalamic 
enzyme activity occurs before recovery in the number of 5-HT uptake sites, 
leading to a continued decrease of indoleamine concentrations. 
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Three and 7 days after the administration of methamphetamine to 
iprindole-treated rats, TPH activity and 5-HT concentrations were de-
creased in all 3 brain regions examined (Figures 1-3). The most pro-
nounced depression in these parameters was seen at 3 days, with a 
partial recovery being observed after 7 days. After 1 day, TPH activity 
in the cerebral cortex, neostriatum and hypothalamus was decreased by 
more than 30%, whereas indoleamine concentrations were not significantly 
different from animals administered saline. These findings suggest that 
a primary action of methamphetamine on the serotonergic system is to 
cause the inhibition of TPH, the rate-limiting enzyme in the synthesis 
of 5-HT. Similar results were obtained using an acute injection of 
methamphetamine; neostriatal, hypothalamic and cortical TPH activities 
were decreased before 5-HT concentrations. 
Although methamphetamine appears to have a primary action on TPH, 
the mechanism by which it depresses the enzyme is not yet apparent. 
Knapp et al. (1974) suggested that it acts directly on TPH; however, 
they did not find an effect of amphetamine on the enzyme in vitro or 
on synaptosomes. They also ruled out the possibility that the drug was 
acting through a metabolic product, an observation supported by the 
present study using a metabolic inhibitor. The possibility exists that 
amphetamine (and methamphetamine) affect TPH and TH activity by altering 
the concentration of the cosubstrate (reduced pterin tetrahydrobio-
pterin) for both enzymes (Mandell, Bullard, Yellin and Russo, 1980). 
The neurotoxic effects of methamphetamine on the serotonergic 
system reported in this study are similar to those seen after injection 
of halogenated amphetamines. p-Chloroamphetamine decreased 5-HT con-
centrations and TPH activity in several brian regions (Sanders-Bush, 
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et al., 1975) with the neostriatum and cerebral cortex being particu-
larly sensitive. Increasing the duration of action of methamphetamine 
by inhibiting its metabolism results in prolonged effects on the sero-
tonergic system of the cerebral cortex and neostriatum (Figures 1 and 
3). The hypothalamus appears to be relatively resistant to the effects 
of methamphetamine and p-chloroamphetamine. Although these effects of 
administering methamphetamine to iprindole-treated rats may not be as 
long-lasting as those of p-chloroamphetamine treatment, it is interest-
ing to note that fenfluramine, another halogenated amphetamine, did not 
produce as prolonged a depression of enzyme activity and 5-HT concen-
trations as p-chloroamphetamine. In further support of the hypothesis 
that methamphetamine and the halogenated amphetamines may produce a 
similar neurotoxic effect on the serotonergic system is the finding of 
Ricaurte et ale (1980) that both drugs produce a loss of synaptosomal 
5-HT uptake sites. 
Administration of methamphetamine to iprindole-treated rats caused 
decreases in both neostriatal TH activity and DA concentrations (Figure 
4). Enzyme activity was decreased by 50% and DA concentrations by 73% 
at 3 days. No recovery was noted by 14 days in either parameter. These 
findings are in agreement with those of Steranka (1981) who reported 
that administration of a single dose of amphetamine sulfate (9.2 mg/kg) 
to rats treated with iprindole hydrochloride (10 mg/kg) produced marked 
decreases in neostriatal concentrations of DA and its metabolites. These 
effects were apparent 'by 12 hours and persisted for at least 4 weeks. 
Although Steranka (1981) observed significant decreases in neostriatal 
dopamine concentrations after 7 days using a dose of amphetamine sulfate 
of 9.2 mg/kg, in the study reported here a dose of methamphetamine of 
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17.5 mg/kg was required to produce a significant decrease. This 
suggests, perhaps, that the dopaminergic system in the neostriatum is 
more sensitive to the neurotoxic effects of amphetamine than methamphet-
amine. 
There was a difference in the responses of the neostriatal dopa-
minergic and serotonergic system to the administration of iprindole and 
methamphetamine. One day following treatment decreases in TPH and TH 
activities were observed; however, neurotransmitter concentrations were 
only significantly decreased in the dopaminergic system. Bakhit et al. 
(in press) and Ricaurte et al. (1980) have shown that the chronic admin-
istration of methamphetamine produces long-lasting depletions of re-
gional 5-HT and DA concentrations and have suggested that the seroton-
ergic system is more sensitive than the dopaminergic system to the 
apparent neurotoxic effects of the drug. The results of this study 
indicate, however, that after single doses of the drug in the presence 
of a metabolic inhibitor, greater changes are observed in the dopamin-
ergic system after 1 day. Changes in enzyme activity occur at an earlier 
time point in the serotonergic system than changes in the neurotrans-
mitter concentrations whereas TH activity and DA concentrations are 
affected at approximately the same time point. 
The effects of a single dose of methamphetamine are also different 
in the neostriatal serotonergic and dopaminergic systems with a signifi-
cant decrease still observed in both TH activity and DA concentrations 
after 24 hours (~igure 4), but not in TPH activity, 5-HT or 5-HIAA con-
centrations (Figure 3). This suggests that the effects of the drug are 
more readily reversible in the serotonergic than the dopaminergic system 
and is supported by the earlier work of Hotchkiss and Gibb (1980) who 
showed that prolonged depression of neostriatal TPH activity only 
occurred after 3 doses of methamphetamine, whereas TH activity was 
irreversibly depressed after 2 doses. The finding of a decrease of 
neostriatal TH activity 24 hours after a single dose is in agreement 
with that of Kogan et ale (1976). 
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The effects of iprindole alone on the serotonergic system of the 
cerebral cortex was unexpected. After a single injection (10 mg/kg) 
TPH activity was increased to 138% of saline control at 1 day and then 
fell to 82% of control at 3 days; 5-HT and 5-HIAA concentrations were 
significantly increased after 3 days (Figure l3). These parameters had 
recovered by 7 days. No changes were seen in Try concentrations after 
1 or 3 days, nor at time points earlier than 1 day. The effects of 
other antidepressants on cortical TPH activity, 5-HT, 5-HIAA and Try 
concentrations were also examined 24 hours after a single injection 
(Table 5). Cloimipramine, amitriptyline and chlorpromazine acted in a 
similar fashion to iprindole; cloimipramine and chlorpromazine also 
increased 5-HIAA concentrations. Desipramine increased 5-HT and 5-HIAA 
concentrations, without significantly changing TPH activity. Cloimi-
pramine was the only agent to increase Try concentrations. Fluoxetine, 
a selective 5-HT uptake blocker, increased 5-HT concentrations. 
Other workers have reported effects of antidepressant drugs on the 
serotonergic system. Hussein and Goedde (1980) reported that 10 daily 
doses of imipramine (20 mg/kg) increased TPH activity in the rabbit 
mesencephalon and pons medulla, with a concomitant decrease in the Km 
for Try. Chlorpromazine behaved similarly to imipramine without low-
ering the Km value. Neckers et ale (1977) found that cloimipramine 
decreased midbrain Try content and increased TPH activity in rat 
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forebrain after a single injection. Badawy and Evans (1981) reported 
that a single dose (10 mg/kg) of several antidepressants inhibited rat 
liver tryptophan pyrrolase, the enzyme responsible for the conversion 
of Try to N-formylkynurenine; this results in an increase in brain Try 
concentrations after 3.5 hours. Although iprindole was effective in 
increasing brain Try concentration, chlorpromazine was shown to be in-
effective. 
These effects of the antidepressants may not necessarily be linked 
to the clinical efficacy of the drugs, as therapeutic benefit commonly 
takes 2 weeks to become apparent. Traditionally, it was thought that 
the typical antidepressants act by increasing aminergic transmission 
through reuptake blockade of NE or 5-HT or both. This hypothesis has 
been questioned because of the existence of "atypical antidepressants," 
such as iprindole and mianserin, which are not efficient reuptake 
blockers but are clinically effective, and by the fact that although 
these biochemical effects occur soon after the drugs are administered, 
the therapeutic effect requires more time to develop. More recent work 
has shown that treatment of rats with antidepressants for 2 weeks re-
duces the sensitivity of B-adrenergic receptors in brain, implying that 
antidepressants act be decreasing, rather than increasing, postsynaptic 
noradrenergic transmission. They are compatible, however, with the 
finding that typical antidepressants block amine reuptake. At least 
part of the subsensitivity produced by some of the drugs may be a con-
sequence of reuptake inhibition, the resultant high synaptic cleft con-
centrations of NE would desensitize the receptor. 
The action of iprindole on the cortical serotonergic system may 
indicate that this antidepressant, and possibly others, regulate the 
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neuronal conversion of Try to 5-HT. Mandell and Knapp (1977) have 
shown that there is a low and high affinity uptake system for Try in 
synaptosomal preparations from 5-HT rich areas and that the high affinity 
system is specific for Try. Lithium chloride induced a dose- and time-
related increase in the relative velocity of high affinity uptake of 
Try and thus an increased conversion of Try to 5-HT. Short-term treat-
ment increases the uptake and the capacity for intact striatal synapto-
somes to convert Try to 5-HT. Long-term treatment maintains the in-
crease in uptake and leads to a compensatory decrease in soluble enzyme 
activity. The interaction of the increased uptake and decreased enzyme 
is an eventual return to a control level. It is possible that this in-
creased conversion is due to an increase in the brain Try concentration, 
a reported finding of lithium chloride administration (Fernstrom and 
Wurtman, 1971); however, experiments by Mandell and Knapp (1977) have 
indicated that at high doses of Try the intrasynaptosomal pool may be 
driven by whole brain concentrations and diffusion, whereas at lower 
levels the brain cell membrane uptake system is limiting. 
It is possible that a single injection of iprindole produces 
changes in the high affinity uptake system resulting initially in an 
increased conversion of Try to 5-HT, followed by a compensatory decrease 
in TPH activity and eventually a return to a control situation. The 
finding that iprindole only alters the cortical serotonergic system is 
difficult to explain. Selective distribution of the drug in different 
brain regions may be the answer; this certainly occurs with amphetamine 
(Eison et al., 1981), explaining why certain regions are relatively 
resistant to its effects. 
70 
The effects of PCP on the neostriatal serotonergic system were not 
as dramatic as those of methamphetamine. The only significant changes 
were an increase in 5-HIAA concentrations at 15 and 30 minutes after 
an acute injection of 10 mg/kg (Figure 14), which may reflect an in-
crease in release and turnover of 5-HT. An acute injection of meth-
amphetamine (10 mg/kg) also increased neostriatal 5-HIAA concentrations 
soon after injection, although at later time points 5-HT concentrations 
were decreased. Unlike the effects of subacute and chronic metham-
phetamine treatment on neostriatal 5-HT and 5-HIAA concentrations, 
similar treatments with PCP did not alter these properties. 
Cerebellar GAD activity was, however, depressed by subacute admin-
istration of PCP (Figure 15); an effect noticeable 12 hours after 4 
doses of 5 and 10 mg/kg. This effect did not occur until 6 hours 
after the last injection and enzyme activity had recovered by 24 hours 
(Figure 16). These effects were not seen after both acute and chronic 
administration and were not apparent in other brain regions examined. 
This effect on GAD activity in the cerebellum may well be secondary to 
the actions of PCP on the noradrenergic system. Marwaha et ale (1980) 
have shown by electrophysiological techniques that PCP mimics the action 
of norepinephrine on cerebellar Purkinje cells possibly by increasing 
release and blocking reuptake. Stimulation of the nucleus locus 
coeruleus, or local application of norepinephrine, elicits a slowing 
of spontaneous discharge, accompanied by hyperpolarization and increased 
resistance of the Purkinje cell membrane (Hoffer, Siggins, Oliver and 
Bloom, 1973). Purkinje cell terminals contain GAD and their hyper-
polarization may result in an inhibition of enzyme activity, possibly 
accounting for the convulsant activity of large doses of PCP seen in 
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some species. 
In conclusion, we have demonstrated that increasing the duration 
of action of methamphetamine by administering iprindole as a metabolic 
inhibitor, produces long-term changes in the serotonergic system of 
the cerebral cortex, neostriatum and hypothalamus and in the dopa-
minergic system of the neostriatum. This study suggests that the 
neurotoxic effects of methamphetamine closely resemble those of the 
halogenated amphetamines on the serotonergic system. Injection of 
iprindole alone produced changes in the cortical serotonergic system, 
possibly reflecting a regulatory phenomenon of this antidepressant on 
either TPH activity or uptake of Try. This finding may be of impor-
tance in the understanding of the regulation of the 5-HT system and 
may also reflect subtle changes seen shortly after antidepressant 
therapy. 
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